270 related articles for article (PubMed ID: 22051859)
1. Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.
Crain MJ; Williams PL; Griner R; Tassiopoulos K; Read JS; Mofenson LM; Rich KC;
Pediatr Infect Dis J; 2011 Dec; 30(12):1069-74. PubMed ID: 22051859
[TBL] [Abstract][Full Text] [Related]
2. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
[TBL] [Abstract][Full Text] [Related]
3. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.
Williams PL; Marino M; Malee K; Brogly S; Hughes MD; Mofenson LM;
Pediatrics; 2010 Feb; 125(2):e250-60. PubMed ID: 20083530
[TBL] [Abstract][Full Text] [Related]
4. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
Williams PL; Yildirim C; Chadwick EG; Van Dyke RB; Smith R; Correia KF; DiPerna A; Seage GR; Hazra R; Crowell CS;
Lancet HIV; 2020 Jan; 7(1):e49-e58. PubMed ID: 31740351
[TBL] [Abstract][Full Text] [Related]
5. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
[TBL] [Abstract][Full Text] [Related]
6. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
Alimenti A; Burdge DR; Ogilvie GS; Money DM; Forbes JC
Pediatr Infect Dis J; 2003 Sep; 22(9):782-9. PubMed ID: 14506368
[TBL] [Abstract][Full Text] [Related]
7. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.
Griner R; Williams PL; Read JS; Seage GR; Crain M; Yogev R; Hazra R; Rich K;
AIDS Patient Care STDS; 2011 Jul; 25(7):385-94. PubMed ID: 21992592
[TBL] [Abstract][Full Text] [Related]
8. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.
Ekouevi DK; Touré R; Becquet R; Viho I; Sakarovitch C; Rouet F; Towne-Gold B; Fassinou P; Leroy V; Blanche S; Dabis F;
Pediatrics; 2006 Oct; 118(4):e1071-7. PubMed ID: 16950945
[TBL] [Abstract][Full Text] [Related]
9. Risk for Speech and Language Impairments in Preschool Age HIV-exposed Uninfected Children With In Utero Combination Antiretroviral Exposure.
Rice ML; Russell JS; Frederick T; Purswani M; Williams PL; Siberry GK; Redmond SM; Hoffman HJ; Yao TJ;
Pediatr Infect Dis J; 2018 Jul; 37(7):678-685. PubMed ID: 29278615
[TBL] [Abstract][Full Text] [Related]
10. Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.
Nozyce ML; Huo Y; Williams PL; Kapetanovic S; Hazra R; Nichols S; Hunter S; Smith R; Seage GR; Sirois PA;
Pediatr Infect Dis J; 2014 Nov; 33(11):1128-33. PubMed ID: 25361407
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.
Aldrovandi GM; Chu C; Shearer WT; Li D; Walter J; Thompson B; McIntosh K; Foca M; Meyer WA; Ha BF; Rich KC; Moye J
Pediatrics; 2009 Dec; 124(6):e1189-97. PubMed ID: 19933732
[TBL] [Abstract][Full Text] [Related]
12. In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children.
Yao TJ; Malee K; Zhang J; Smith R; Redmond S; Rice ML; Frederick T; Torre P; Mellins CA; Hoffman HJ; Williams PL
AIDS Patient Care STDS; 2023 Mar; 37(3):119-130. PubMed ID: 36827595
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
14. Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States.
Kirmse B; Yao TJ; Hofherr S; Kacanek D; Williams PL; Hobbs CV; Hazra R; Borkowsky W; Van Dyke RB; Summar M
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):339-48. PubMed ID: 26548585
[TBL] [Abstract][Full Text] [Related]
15. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
[TBL] [Abstract][Full Text] [Related]
16. The impact of health programmes to prevent vertical transmission of HIV. Advances, emerging health challenges and research priorities for children exposed to or living with HIV: Perspectives from South Africa.
Goga A; Slogrove A; Wedderburn CJ; Feucht U; Wessels J; Ramokolo V; Bhana A; Du Plessis N; Green RJ; Pillay Y; Sherman G
S Afr Med J; 2019 Dec; 109(11b):77-82. PubMed ID: 32252873
[TBL] [Abstract][Full Text] [Related]
17. Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.
Crowell CS; Williams PL; Yildirim C; Van Dyke RB; Smith R; Chadwick EG; Seage GR; Diperna A; Hazra R;
AIDS; 2020 Jul; 34(9):1377-1387. PubMed ID: 32310900
[TBL] [Abstract][Full Text] [Related]
18. Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa.
Nyemba DC; Kalk E; Madlala HP; Malaba TR; Slogrove AL; Davies MA; Boulle A; Myer L; Powis KM
BMC Pregnancy Childbirth; 2021 May; 21(1):354. PubMed ID: 33947351
[TBL] [Abstract][Full Text] [Related]
19. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
[TBL] [Abstract][Full Text] [Related]
20. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
